By ROBERT CYRAN
The deal with Allergan will cut taxes and add solid assets, but it is also prompting Pfizer to defer until 2018 a decision on splitting up.
Published: November 25, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1R4qeN3
from WordPress http://ift.tt/1T0t5F9
via Hadi Aboukhater
No comments:
Post a Comment